Overview
- Sydney entrepreneur Paul Conyngham pursued a personalized vaccine for his dog Rosie, with UNSW researchers synthesizing the mRNA and first doses given in December 2025.
- Conyngham reports partial tumor shrinkage and improved mobility in the weeks following the injections.
- Researchers emphasize that AI tools like ChatGPT, AlphaFold and Grok acted as research aids, with the design and delivery performed by human experts.
- The regimen included a checkpoint inhibitor, leaving the vaccine’s specific impact uncertain as immune-response testing proceeds, according to a scientist involved.
- Coverage has shifted from viral claims of an AI-driven cure to a cautious view that this is a resource-intensive proof of possibility complicated by significant ethics and regulatory hurdles.